Your browser doesn't support javascript.
loading
Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis.
Papp, K; Bachelez, H; Costanzo, A; Foley, P; Gooderham, M; Kaur, P; Philipp, S; Spelman, L; Zhang, N; Strober, B.
Affiliation
  • Papp K; Clinical Research, Waterloo, ON, Canada.
  • Bachelez H; Probity Medical Research, Waterloo, ON, Canada.
  • Costanzo A; Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France.
  • Foley P; Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy.
  • Gooderham M; Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia.
  • Kaur P; Skin & Cancer Foundation Inc., Carlton, Australia.
  • Philipp S; Probity Medical Research, Carlton, Australia.
  • Spelman L; Probity Medical Research, Waterloo, ON, Canada.
  • Zhang N; SKiN Centre for Dermatology, ON, Canada.
  • Strober B; Amgen Inc., Thousand Oaks, CA, U.S.A.
Br J Dermatol ; 177(6): 1562-1574, 2017 12.
Article in En | MEDLINE | ID: mdl-28755394

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Dermatologic Agents / Biosimilar Pharmaceuticals / Adalimumab Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Psoriasis / Dermatologic Agents / Biosimilar Pharmaceuticals / Adalimumab Type of study: Clinical_trials Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Dermatol Year: 2017 Document type: Article Affiliation country: Canada Country of publication: United kingdom